Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE rimonabant advice withdrawn

The National Institute for Heath and Clinical Excellence has withdrawn its guidance on the use of rimonabant for the treatment of overweight and obese patients.

The withdrawal of this guidance is as a result of suspension of the marketing authorisation for rimonabant (Acomplia®) by the European Medicines Agency (EMEA) for safety reasons.

Action: Clinicians should already be aware of this license suspension. No new prescriptions should be issued and patients should be advised that it is safe to stop treatment at any time.

Share 'NICE rimonabant advice withdrawn' on Email Share 'NICE rimonabant advice withdrawn' on Delicious Share 'NICE rimonabant advice withdrawn' on Digg Share 'NICE rimonabant advice withdrawn' on Facebook Share 'NICE rimonabant advice withdrawn' on Google+ Share 'NICE rimonabant advice withdrawn' on reddit Share 'NICE rimonabant advice withdrawn' on StumbleUpon Share 'NICE rimonabant advice withdrawn' on Twitter

atomic-wealth

No Comments to “NICE rimonabant advice withdrawn”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,309 spam comments.

atomic-wealth
fond-illness
summer